Tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mesencephalic cultures after MPP+: The consequences of treatment with GM1 ganglioside

Brain Research

Volumn 742, Issue 1-2, 1996, Pages 260-264

  Dalia, Asad ^a   Neff, Norton H ^a   Hadjiconstantinou, Maria ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

1 methyl 4 phenylpyridinium (MPP+); aromatic L amino acid decarboxylase; GM1 ganglioside; mesencephalic culture; recovery; tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE DERIVATIVE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; GANGLIOSIDE GM1; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; CELLS, CULTURED; FEMALE; G(M1) GANGLIOSIDE; MESENCEPHALON; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 0030566684     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01010-4     Document Type: Article

References (20)

1. Beck K.D., Knusel B., Pasinetti G., Michel P.P., Zawadzka H., Goldstein M., Hefti F. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenylpyridinium treatment. J. Neurochem. 57:1991;527-532.
2. Cuello A.C. Glycosphingolipids that can regulate nerve growth and repair. Adv. Pharmacol. 21:1990;1-50.
3. +. J. Neurosci. 13:1993;3104-3111.
4. Eaton M.J., Gudehithlu K.P., Quach T., Silvia C.P., Hadjiconstantinou M., Neff N.H. Distribution of aromatic L-amino acid decarboxylase mRNA in mouse brain by in situ hybridization histology. J. Comp. Neurol. 337:1993;640-654.
5. Friedman L., Mytilineou C. The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations. Neurosci. Lett. 79:1987;65-72.
6. Hadjiconstantinou M., Mariani A.P., Neff N.H. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Brain Res. 484:1989;297-303.
7. Hadjiconstantinou M., Neff N.H. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 51:1988;1190-1196.
8. Hadjiconstantinou M., Neff N.H. Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment. Eur. J. Pharmacol. 181:1990;137-139.
9. Hadjiconstantinou M., Rossetti Z.L., Paxton R.C., Neff N.H. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Neuropharmacology. 25:1986;1075-1077.
10. Hadjiconstantinou M., Weihmuller F.B., Neff N.H. Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP. Eur. J. Pharmacol. 168:1989;261-264.
11. Herrero M.T., Perez-Otano I., Oset C., Kastner A., Hirsch E.C., Agid Y., Luquin M.R., Obeso J.A., Del Rio J. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience. 56:1993;965-972.
12. Leon A., Dal Toso R., Presti D., Benvegnu D., Facci L., Kirschner G., Tettamanti G., Toffano G. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides. J. Neurosci. 8:1988;746-753.
13. Li X.-M., Juorio A.V., Paterson I.A., Walz W., Zhu M.-Y., Boulton A.A. Gene expression of aromatic L-amino acid decarboxylase in rat cultured glial cells. J. Neurochem. 59:1992;1172-1175.
14. O'Malley K.L., Harmon S., Moffat M., Uhland-Smith A., Wong S. The human aromatic L-amino acid decarboxylase gene can be alternatively spliced to generate unique protein isoforms. J. Neurochem. 65:1995;2409-2416.
15. Reinhard J.F. Jr., Miller D.B., O'Callaghan J.P. The neuro-toxicant MPTP (1 methyl-4- phenyl-1,2,3,6,-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury. Neurosci. Lett. 8:1988;246-251.
16. Schengrund C.L. The role(s) of gangliosides in neural differentiation and repair: a perspective. Brain Res. Bull. 24:1990;131-141.
17. Schneider J.S., Pope A., Simpson K., Taggart J., Smith M.G., DiStefano L. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Science. 256:1992;843-846.
18. +-induced damage: dependence on initial damage and time of treatment. Brain Res. 640:1994;308-315.
19. Weihmuller F.B., Hadjiconstantinou M., Bruno J.P., Neff N.H. Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice. Neurosci. Lett. 92:1988;207-212.
20. Weihmuller F.B., Hadjiconstantinou M., Bruno J.P., Neff N.H. Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice. Life Sci. 45:1989;2495-2502.